Skip to main content
. 2017 Nov 9;18(11):2378. doi: 10.3390/ijms18112378

Figure 4.

Figure 4

Figure 4

Release of the prostanoids prostaglandin (PG)F (A), thromboxane (Tx)B2 (a stable metabolite of TxA2) (B), PGE2 (C), and 6-keto-PGF (a stable metabolite of PGI2) (D), evoked by uridine adenosine tetraphosphate (Up4A; 3 × 10−5 mol/L) or vehicle (water) in aortic rings obtained from LETO (n = 7) and OLETF (n = 7) rats. The y-axis shows amounts of prostanoids expressed as pg/mg wet weight of aortic ring. Each column represents means ± standard error. * p < 0.05 vs. Up4A LETO. LETO, Long-Evans Tokushima Otsuka rats; OLETF, Otsuka Long-Evans Tokushima Fatty rats; n.s., not significant.